6666 related articles for article (PubMed ID: 12749752)
1. Gangliosides as therapeutic targets for cancer.
Fredman P; Hedberg K; Brezicka T
BioDrugs; 2003; 17(3):155-67. PubMed ID: 12749752
[TBL] [Abstract][Full Text] [Related]
2. Ganglioside antigens expressed by human cancer cells.
Ritter G; Livingston PO
Semin Cancer Biol; 1991 Dec; 2(6):401-9. PubMed ID: 1810468
[TBL] [Abstract][Full Text] [Related]
3. Cancer vaccines: an update with special focus on ganglioside antigens.
Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
[TBL] [Abstract][Full Text] [Related]
4. Targeting
Fleurence J; Fougeray S; Bahri M; Cochonneau D; Clémenceau B; Paris F; Heczey A; Birklé S
J Immunol Res; 2017; 2017():5604891. PubMed ID: 28154831
[TBL] [Abstract][Full Text] [Related]
5. Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy.
Labrada M; Clavell M; Bebelagua Y; León Jd; Alonso DF; Gabri MR; Veloso RC; Vérez V; Fernández LE
Expert Opin Biol Ther; 2010 Feb; 10(2):153-62. PubMed ID: 20088712
[TBL] [Abstract][Full Text] [Related]
6. Harnessing potential role of gangliosides in immunomodulation and cancer therapeutics.
Hegde M; Girisa S; Aswani BS; Alqahtani MS; Abbas M; Sethi G; Kunnumakkara AB
Life Sci; 2024 Aug; 351():122786. PubMed ID: 38848944
[TBL] [Abstract][Full Text] [Related]
7. Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy.
Durrant LG; Noble P; Spendlove I
Clin Exp Immunol; 2012 Feb; 167(2):206-15. PubMed ID: 22235996
[TBL] [Abstract][Full Text] [Related]
8. Cancer-Associated Glycosphingolipids as Tumor Markers and Targets for Cancer Immunotherapy.
Groux-Degroote S; Delannoy P
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200284
[TBL] [Abstract][Full Text] [Related]
9. Ganglioside vaccines with emphasis on GM2.
Livingston P
Semin Oncol; 1998 Dec; 25(6):636-45. PubMed ID: 9865678
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Strategies for Human IgM Antibodies Directed at Tumor-Associated Ganglioside Antigens: Discoveries Made During the Morton Era and Future Directions.
Jones PC; Irie RF
Crit Rev Oncog; 2016; 21(1-2):75-81. PubMed ID: 27481004
[TBL] [Abstract][Full Text] [Related]
11. NGcGM3 ganglioside: a privileged target for cancer vaccines.
Fernandez LE; Gabri MR; Guthmann MD; Gomez RE; Gold S; Fainboim L; Gomez DE; Alonso DF
Clin Dev Immunol; 2010; 2010():814397. PubMed ID: 21048926
[TBL] [Abstract][Full Text] [Related]
12. Gangliosides: Structures, Biosynthesis, Analysis, and Roles in Cancer.
Groux-Degroote S; Guérardel Y; Delannoy P
Chembiochem; 2017 Jul; 18(13):1146-1154. PubMed ID: 28295942
[TBL] [Abstract][Full Text] [Related]
13. Role of gangliosides in active immunotherapy with melanoma vaccine.
Ravindranath MH; Morton DL
Int Rev Immunol; 1991; 7(4):303-29. PubMed ID: 1779175
[TBL] [Abstract][Full Text] [Related]
14. The glioma-associated gangliosides 3'-isoLM1, GD3 and GM2 show selective area expression in human glioblastoma xenografts in nude rat brains.
Hedberg KM; Mahesparan R; Read TA; Tysnes BB; Thorsen F; Visted T; Bjerkvig R; Fredman P
Neuropathol Appl Neurobiol; 2001 Dec; 27(6):451-64. PubMed ID: 11903928
[TBL] [Abstract][Full Text] [Related]
15. Ganglioside composition and histology of a spontaneous metastatic brain tumour in the VM mouse.
El-Abbadi M; Seyfried TN; Yates AJ; Orosz C; Lee MC
Br J Cancer; 2001 Jul; 85(2):285-92. PubMed ID: 11461091
[TBL] [Abstract][Full Text] [Related]
16.
Cavdarli S; Delannoy P; Groux-Degroote S
Cells; 2020 Mar; 9(3):. PubMed ID: 32192217
[No Abstract] [Full Text] [Related]
17. Ganglioside-based vaccines and anti-idiotype antibodies for active immunotherapy against cancer.
Fernández LE; Alonso DF; Gomez DE; Vázquez AM
Expert Rev Vaccines; 2003 Dec; 2(6):817-23. PubMed ID: 14711364
[TBL] [Abstract][Full Text] [Related]
18. Expression analysis of 0-series gangliosides in human cancer cell lines with monoclonal antibodies generated using knockout mice of ganglioside synthase genes.
Bhuiyan RH; Kondo Y; Yamaguchi T; Tokuda N; Ohkawa Y; Hashimoto N; Ohmi Y; Yamauchi Y; Furukawa K; Okajima T; Furukawa K
Glycobiology; 2016 Sep; 26(9):984-998. PubMed ID: 27102283
[TBL] [Abstract][Full Text] [Related]
19. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
Hakomori S
Cancer Res; 1996 Dec; 56(23):5309-18. PubMed ID: 8968075
[TBL] [Abstract][Full Text] [Related]
20. An epitope common to gangliosides O-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapy.
Ravindranath MH; Morton DL; Irie RF
Cancer Res; 1989 Jul; 49(14):3891-7. PubMed ID: 2472199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
